Cytek Biosciences, Inc. (CTKB) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $97.03M | +8.6% |
| 2024 | $89.35M | +6.9% |
| 2023 | $83.59M | +32.6% |
| 2022 | $63.06M | +29.2% |
| 2021 | $48.81M | +18.7% |
| 2020 | $41.13M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $97.03M | +8.6% |
| 2024 | $89.35M | +6.9% |
| 2023 | $83.59M | +32.6% |
| 2022 | $63.06M | +29.2% |
| 2021 | $48.81M | +18.7% |
| 2020 | $41.13M | — |